CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP
· Real-Time Price · USD
57.61
-2.12 (-3.55%)
At close: Aug 18, 2025, 3:59 PM
57.89
0.49%
After-hours: Aug 18, 2025, 06:26 PM EDT
CRISPR Therapeutics Revenue
CRISPR Therapeutics reported an annual revenue of $35M, reflecting a -90.57% growth. For the quarter ending June 30, 2025, CRISPR Therapeutics generated $892K in revenue.
Revenue (ttm)
35M
Revenue Growth
-90.57%
Price / Sales Ratio
94.87
Revenue / Employee
89.06K
Employees
393
Market Cap
5.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 35M | -90.57% |
| Dec 31, 2023 | 371.21M | +85038.99% |
| Dec 31, 2022 | 436K | -99.95% |
| Dec 31, 2021 | 913.08M | +168054.88% |
| Dec 31, 2020 | 543K | -99.81% |
| Dec 31, 2019 | 289.59M | +9169.85% |
| Dec 31, 2018 | 3.12M | -92.38% |
| Dec 31, 2017 | 41M | +693.90% |
| Dec 31, 2016 | 5.16M | +1990.69% |
| Dec 31, 2015 | 247K | +Infinity% |
| Dec 31, 2014 | 0 | n/a |